PYXS

Pyxis Oncology Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth↓ 0/10
  • Momentum↓ 2/10
Pyxis Oncology sales and earnings growth
PYXS Growth
Low
  • Revenue Y/Y↓ -82.53%
  • EPS Y/Y↓ -54.37%
  • FCF Y/Y↓ -34.34%
Pyxis Oncology gross and profit margin trends
PYXS Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -3442.80%
  • ROIC↓ -85.40%
Pyxis Oncology net debt vs free cash flow
PYXS Risk
Great
  • Debt / Equity↓ 0.3
  • Debt / FCF↓ 0.1
  • Interest coverage↓ NA

Pyxis Oncology stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗